After weeks of speculation, Healthscope has finally agreed on a buy-out by US private equity giants The Carlyle Group and TPG Capital, in a deal that values the Australian private healthcare provider at AUS$2.7bn ($2.35bn).
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.